1 terminated. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Terminated 1 |
Follow Urticaria: new trials by email Literature Review of Urticaria trials Research Report on Urticaria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Research Into the Effect of a Clot-dissolving Agent and Its Inhibitor M5, C1-inhibitor - Acute Ischemic Stroke | Early Phase 1 | Terminated | TSI, LLC | 8 | 2012-09-01 | 2021-01-19 |
Angioedemas, Hereditary (1) · Brain Infarction (1) · Brain Ischemia (1) · Cardiovascular Diseases (1) · Cerebral Infarction (1) · Cerebrovascular Disorders (1) · Ischemia (1) · Ischemic Stroke (1) · Stroke (1) · Vascular Diseases (1)
Angioedema (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Hereditary Complement Deficiency Diseases (1) · Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Infarction (1) · Necrosis (1) · Nervous System Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Complement C1 Inhibitor Protein (1)
TSI, LLC (1)
Netherlands (1)